Phathom Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
PHAT Nasdaq 2830 www.phathompharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT): Are Analysts Optimistic? - Jun 28th, 2025 8:14 am
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 23rd, 2025 2:15 pm
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary - Jun 23rd, 2025 5:59 am
Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032 - Jun 16th, 2025 6:00 am
Wall Street Analysts Believe Phathom Pharmaceuticals (PHAT) Could Rally 107.4%: Here's is How to Trade - Jun 9th, 2025 7:55 am
Top Midday Gainers - Jun 6th, 2025 12:10 pm
Phathom Pharmaceuticals shares soar on FDA exclusivity grant - Jun 6th, 2025 10:45 am
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032 - Jun 6th, 2025 10:27 am
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - May 15th, 2025 5:59 am
After Plunging -45.82% in 4 Weeks, Here's Why the Trend Might Reverse for Phathom Pharmaceuticals (PHAT) - May 8th, 2025 7:35 am
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Just Reported, And Analysts Assigned A US$18.63 Price Target - May 4th, 2025 7:54 am
Phathom Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations - May 3rd, 2025 7:15 am
Phathom Pharmaceuticals Inc (PHAT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - May 2nd, 2025 1:02 am
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates - May 1st, 2025 6:15 am
Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - May 1st, 2025 5:00 am
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting - Apr 28th, 2025 5:59 am
Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025 - Apr 23rd, 2025 6:00 am
Phathom Pharmaceuticals (NASDAQ:PHAT) shareholders have endured a 87% loss from investing in the stock five years ago - Apr 17th, 2025 6:46 am
Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors - Apr 16th, 2025 6:00 am
Rhythm Pharmaceuticals (RYTM) Surges 17.1%: Is This an Indication of Further Gains? - Apr 8th, 2025 5:09 am